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Unfortunately the original version of this article [1] con-
tained an error. The subheadings within the abstract
were included incorrectly. The correct subheadings and
complete abstract can be found corrected below:
Abstract
Background
The aim of this review was to identify and evaluate exist-
ing research to determine the clinical effectiveness and
safety of prolotherapy injections for treatment of lower
limb tendinopathy and fasciopathy.
Methods
Nine databases were searched (Medline, Science Dir-
ect, AMED, Australian Medical Index, APAIS-Health,
ATSIhealth, EMBASE, Web of Science, OneSearch) with-
out language, publication or data restrictions for all
relevant articles between January 1960 and September
2014. All prospective randomised and non-randomised
trials, cohort studies, case-series, cross-sectional studies
and controlled trials assessing the effectiveness of one or
more prolotherapy injections for tendinopathy or fascio-
pathy at or below the superior aspect of the tibia/fibula
were included. Methodological quality of studies was
determined using a modified evaluation tool developed by
the Cochrane Musculoskeletal Injuries Group. Data ana-
lysis was carried out to determine the mean change of out-
come measure scores from baseline to final follow-up for
trials with no comparative group, and for randomised
controlled trials, standardised mean differences between
intervention groups were calculated. Pooled SMD data
were calculated where possible to determine the statistical* Correspondence: lanemsanderson@gmail.com
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Results
Two hundred and three studies were identified, eight of
which met the inclusion criteria. These were then grouped
according to tendinopathy or fasciopathy being treated
with prolotherapy injections: Achilles tendinopathy, plan-
tar fasciopathy and Osgood-Schlatter disease. The meth-
odological quality of the eight included studies was
generally poor, particularly in regards to allocation con-
cealment, intention to treat analysis and blinding proce-
dures. Results of the analysis provide limited support for
the hypothesis that prolotherapy is effective in both redu-
cing pain and improving function for lower limb tendino-
pathy and fasciopathy, with no study reporting a mean
negative or non-significant outcome following prolother-
apy injection. The analysis also suggests prolotherapy
injections provide equal or superior short-, intermediate-
and long-term results to alternative treatment modalities,
including eccentric loading exercises for Achilles tendino-
pathy, platelet-rich plasma for plantar fasciopathy and
usual care or lignocaine injections for Osgood-Schlatter
disease. No adverse events following prolotherapy injec-
tions were reported in any study in this review.
Conclusions
The conclusions of this review were derived from the best
available scientific evidence. It is intended that the results
of this study will assist clinical decision-making by practi-
tioners. The results of this review found limited evidence
that prolotherapy injections are a safe and effective treat-
ment for Achilles tendinopathy, plantar fasciopathy and
Osgood-Schlatter disease, however more robust research
using large, methodologically-sound randomised con-
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